Edwin Krebs

Edwin Krebs was an American biochemist and molecular biologist whose work established reversible protein phosphorylation as a central regulatory mechanism in cell biology, physiology, and biochemistry. His research, often conducted in collaboration with Edmond H. Fischer, led to the discovery of protein kinases and phosphatases as enzymes that regulate cellular processes; this contribution earned them the Nobel Prize in Physiology or Medicine in 1992. Krebs's findings influenced studies across oncology, endocrinology, neuroscience, and immunology, shaping modern understanding of signal transduction and disease mechanisms.

Early life and education

Krebs was born in Spokane, Washington and raised in a family connected with the Pacific Northwest, where he attended local schools before matriculating at Gonzaga University for undergraduate studies. He pursued graduate work at Washington State University, obtaining training in chemistry and physiology that bridged laboratory techniques and biomedical questions prominent in mid-20th-century biomedicine. For medical and research training, he attended the University of Washington School of Medicine, where exposure to faculty working on enzyme kinetics and metabolic regulation—figures associated with institutions such as Harvard Medical School and the Rockefeller University—shaped his interests. During this period he interacted with peers and mentors who were active in postwar expansions of biomedical research at centers including the National Institutes of Health and university medical centers.

Research and discoveries

Krebs's seminal work, often in partnership with Edmond H. Fischer, elucidated that many proteins undergo reversible modification by phosphorylation, a process mediated by enzymes they characterized as protein kinases and protein phosphatases. Using preparations of glycogen phosphorylase from tissues studied by groups working in contexts such as Carbogen Laboratories and classical enzymology labs, Krebs and colleagues showed that cyclic regulation involved covalent addition and removal of phosphate groups from serine or threonine residues on target proteins. This discovery linked biochemical events to hormonal control systems investigated by laboratories at Yale University, Columbia University, and Johns Hopkins University and provided mechanistic insight relevant to signaling pathways later explored at institutions like Cold Spring Harbor Laboratory and Salk Institute.

Their experiments employed chromatographic separation, radiolabeling methods refined in labs influenced by George K. A. Bell-style techniques, and kinase assays that became standard tools in the field. The conceptual advance—that reversible phosphorylation is a universal switch in processes ranging from glycogen metabolism to cell division—created a framework adopted by researchers studying receptors and cascades such as the insulin receptor pathway, MAPK pathway, and PI3K–Akt pathway. Subsequent work by labs at MIT, University of California, San Francisco, and Stanford University built on Krebs's findings to map phosphorylation networks implicated in cancer, diabetes mellitus, Alzheimer's disease, and immune signaling in contexts like the major histocompatibility complex studies.

Career and positions

Krebs spent much of his professional life at the University of Washington, where he led laboratories and mentored trainees who went on to careers at institutions such as Harvard University, University of California, Berkeley, and European Molecular Biology Laboratory. He held faculty appointments that connected departmental programs in biochemistry and medicine and collaborated with clinical investigators at hospitals affiliated with the university, including Harborview Medical Center and University of Washington Medical Center. Later associations included roles with research organizations like the Fred Hutchinson Cancer Center and advisory positions for funding bodies including the National Science Foundation and National Institutes of Health study sections. He served on editorial boards of journals that defined the field, interacting with editors at publications such as Nature, Science, and the Journal of Biological Chemistry.

Awards and honors

Krebs received numerous honors recognizing the impact of his work on biomedical science. The most prominent award was the Nobel Prize in Physiology or Medicine (1992), shared with Edmond H. Fischer, acknowledging discovery of reversible protein phosphorylation as a biological regulatory mechanism. He was also a recipient of the Albert Lasker Award for Basic Medical Research and the National Medal of Science, and he was elected to the National Academy of Sciences and the American Academy of Arts and Sciences. Professional societies such as the American Society for Biochemistry and Molecular Biology and the Royal Society (honorary associations) acknowledged his contributions, and universities conferred honorary degrees from institutions including Harvard University and University of Pennsylvania. Lectureships and named seminars at centers such as Cold Spring Harbor Laboratory and Rockefeller University further commemorated his influence.

Personal life and legacy

Krebs maintained ties to the Pacific Northwest community around Seattle and remained engaged with scientific mentorship and advisory activity after formal retirement; colleagues from centers like Fred Hutchinson Cancer Center and the University of Washington often cited his guidance. His legacy is evident in the proliferation of kinase-targeted therapeutics developed by pharmaceutical companies and research consortia including GlaxoSmithKline, Pfizer, and academic drug-discovery programs at Broad Institute. Textbooks in biochemistry and cell biology routinely feature his work, and databases cataloging phosphoproteomes at institutions such as European Bioinformatics Institute and National Center for Biotechnology Information trace conceptual roots to his discoveries. He is remembered by trainees and collaborators who advanced fields spanning signal transduction, structural biology, and systems biology, ensuring that reversible phosphorylation remains a foundational principle in modern biomedical research.

Category:American biochemists Category:Nobel laureates in Physiology or Medicine Category:University of Washington faculty